JESSICA REUSS: Open Payments
NPI 1427532100 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $173 |
| Lilly USA, LLC | 6 | $114 |
| Novo Nordisk Inc | 2 | $30 |
| ALK-Abello, Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Organon LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, MOUNJARO, BREZTRI, Ozempic, NEFFY, SHINGRIX, NURTEC ODT, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
